Neutralization of Staphylococcus aureus Protein A Prevents Exacerbated Osteoclast Activity and Bone Loss during Osteomyelitis

Authors:

Abstract
Osteomyelitis caused by Staphylococcus aureus is an important and current health care problem worldwide. Treatment of this infection frequently fails not only due to the increasing incidence of antimicrobial-resistant isolates but also because of the ability of S. aureus to evade the immune system, adapt to the bone microenvironment, and persist within this tissue for decades.
Funding Information
  • Fundación Científica Felipe Fiorellino (&#45, &#45)
  • Burroughs Wellcome Fund and by the G. Harold and Leila Y. Mathers Charitable Foundation (Career Award for Medical Scientists)
  • HHS | NIH | National Institute of Allergy and Infectious Diseases (RO1AI145992)
  • HHS | NIH | National Institute of Allergy and Infectious Diseases (RO1AI161022)
  • HHS | NIH | National Institute of Allergy and Infectious Diseases (RO1AI132560)
  • MINCyT | Agencia Nacional de Promoción Científica y Tecnológica (PICT-2016-2678)
  • MINCyT | Agencia Nacional de Promoción Científica y Tecnológica (PICT-2018-3613)
  • MINCyT | Agencia Nacional de Promoción Científica y Tecnológica (PICT-2020-2352)

This publication has 72 references indexed in Scilit: